Unavailability of Pentothal injection

The firm Hospira, marketing authorisation holder of Pentothal in vials containing 1 g of thiopental powder (for solution IV), has decided to stop for good the marketing of this product. Whilst waiting for a lasting solution to the availability situation and to meet the needs of patients, pharmacists can import a thiopental-containing medicine for injection approved and marketed abroad, as long as certain conditions are met.

See other languages (French or Dutch).

Last updated on 23/01/2013